News: India’s first COVID-19 vaccine candidate COVAXIN has received the approval of Drug Controller General of India(DCGI) for phase I and II of human clinical trials. Facts: COVAXIN: It is an inactivated vaccine created from a strain of the infectious SARS-CoV-2 virus. Developed by: It has been developed by Bharat Biotech in collaboration with the… Continue reading India’s first COVID-19 vaccine candidate COVAXIN gets DCGI approval
Tag: DGCI
Search Articles
Latest Articles
- India’s urban water crisis-From Bengaluru to Chennai and beyond
- Limitation of Welfare Policies Politics in India
- Challenges of implementing a wealth tax: Piketty’s wealth tax: An idea that just can’t work
- Avoid pre-trial injunctions against the media in defamation cases: Timely restatement
- Impact of politics on humanitarian aid: The politics of humanitarian aid
- Investment Facilitation for Development (IFD): WTO’s investment facilitation negotiations are not illegal
- Sustainable building materials
- [Download] New 10 PM Weekly Compilation – March 2024 – 3rd week
- [Answered] UPSC Mains Answer writing 27 Mar, 2024 I Mains Marathon
- UPSC Prelims Marathon 28th March – Tax Structure in India – 2024